Improving care delivery for patients with rare cancers: A phase II trial of durvalumab in combination with tremilumimab in subjects with advanced rare tumors in a large community health care system.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e18535
Abstract: e18535Background: Patients with rare cancers are an underserved population with limited access to clinical trials aside from Phase I trials in the refractory setting. Providing access to immunother... read more here.
Keywords: care delivery; patients rare; delivery patients; rare cancers ... See more keywords